ModerateAtypical antipsychotic – dibenzodiazepine×Proton pump inhibitors
Updated · Methodology
Mechanism
In the liver, CYP1A2 and CYP3A4 metabolise almost all of the clozapine, with some contribution from CYP2C19 and CYP2D6 (clozapine SmPC). The clozapine SmPC lists omeprazole among CYP1A2 inducers. When the two drugs are taken together, clozapine levels can fall, and treatment can become less effective. When the inducer is stopped, clozapine levels can rise, and so can the risk of adverse reactions (Clozaril label, US Food and Drug Administration, FDA). Omeprazole also inhibits CYP2C19 (omeprazole SmPC), but the clozapine SmPC says the effect of CYP2C19 inhibition may be minimal. Severe hypomagnesaemia has been reported after at least three months of proton pump inhibitor treatment (omeprazole SmPC). During clozapine treatment, low magnesium raises the risk of QT prolongation (Clozaril label, FDA).
Symptoms
Clozapine works less well, and psychotic symptoms return or worsen (clozapine SmPC). If omeprazole is stopped and clozapine levels rise, seizures may occur, and their risk rises with the dose (Clozaril label, US Food and Drug Administration, FDA). During clozapine treatment, hypotension, bradycardia and fainting are more likely with rapid dose increases (Clozaril label, FDA). With long-term omeprazole, hypomagnesaemia shows as fatigue, tetany, delirium, seizures, dizziness and ventricular arrhythmia (omeprazole SmPC).
Management
No document contraindicates the combination. The clozapine SmPC asks prescribers to take into account that omeprazole can lower clozapine levels and effectiveness. It also recommends caution with substances that induce or inhibit cytochrome P450 enzymes (clozapine SmPC). After omeprazole is started, watch for returning psychotic symptoms. For moderate or weak CYP1A2 inducers, the US Food and Drug Administration (FDA) label suggests considering a higher clozapine dose if necessary (Clozaril label, FDA). When omeprazole is stopped, consider a lower clozapine dose, because clozapine levels and the risk of adverse reactions can rise (Clozaril label, FDA). Adjust the clozapine dose individually and use the lowest effective dose (clozapine SmPC). If omeprazole is prescribed long term, consider measuring magnesium before treatment and periodically during it (omeprazole SmPC). Before starting clozapine, measure potassium and magnesium and correct electrolyte disturbances. Then check electrolytes periodically (Clozaril label, FDA).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Omeprazol (Losec 20 mg) (nº registro 58377), secciones 4.4 y 4.5 (2026)– AEMPS, CIMA, nº registro 58377, revisión 06/2026, secciones 4.4 y 4.5
- AEMPS: Ficha técnica: Clozapina – Leponex (nº registro 59547), sección 4.5 (2026)– AEMPS, CIMA, nº registro 59547, revisión 06/2026, secciones 4.4 y 4.5
- FDA: Clozaril (clozapine) prescribing information (2025)– FDA, DailyMed, HLS Therapeutics, setid 90876802-0e3a-44c9-9ff7-1754dfbe736a, v21, 06/2025, sections 5.1, 5.4, 5.5, 7.1
- AEMPS: Ficha técnica: Clozapina (nº registro 59547), secciones 4.9 y 5.2 (2026)– AEMPS, CIMA, nº registro 59547 (Leponex 100 mg comprimidos, Viatris), revisión 06/2026, secciones 4.9 y 5.2